Related Links
ARALAST NP Therapy
Choose a therapy that offers you the support you need.
Alpha-1 as Seen
on PBS
Watch the PBS show about Alpha-1.
Seasonal Allergies
Allergies are nothing to sneeze at, especially for Alphas and others with lung-related ailments such as chronic obstructive pulmonary disease (COPD). During the peak pollen counts of spring, summer and fall, people with Alpha-1 and COPD need to take special care to limit exposure to allergens that can aggravate breathing difficulties.
If you suspect that you have allergies, consult a physician for testing and treatment advice. In the meantime, the following survival tips1 also may help.
- Be ready for allergy season. Plants and trees pollinate in reasonably predictable order every year. Antihistamines taken before exposure to allergy-causing substances can help prevent an outbreak of symptoms.
- Air-condition your car and home and keep your windows closed to keep the pollen out. Clean your air-conditioning units often to prevent the growth of mold. Change your filters regularly.
- Install a high-efficiency media filter with a MERV rating of 12 on your furnace and air-conditioning unit. Leave the fan on to create a "whole house" air filter that removes over 90% of particles that cause allergies. Be sure to change the filter every three months (with the change of the seasons) to keep your air cleaner year-round.
- Avoid windy weather. It can aggravate allergies.
- Wear glasses or sunglasses when outdoors to keep pollen from irritating the eyes.
- Wash your hands often and rinse your eyes with cool water after coming indoors to remove clinging pollen. Wash your hair at night to keep pollens out of bedding.
- Take a vacation at the beach during peak allergy seasons. Ocean breezes can help clear away pollen and relieve allergy symptoms.
ARALAST NP [Alpha1-Proteinase Inhibitor (Human)]
ARALAST NP is indicated for chronic augmentation therapy in patients having congenital deficiency of A1-PI with clinically evident emphysema. ARALAST NP is not indicated as therapy for lung disease patients in whom congenital A1-PI deficiency has not been established.
The effect of augmentation therapy with ARALAST NP on pulmonary exacerbations and on the progression of emphysema in alpha1-antitrypsin deficiency has not been demonstrated in randomized, controlled clinical trials.
Please review the Important Risk Information and the Full Prescribing Information
Please review the Important Risk Information and the Full Prescribing Information
References
- American College of Allergy, Asthma & Immunology. The Public Education: Survival Tips For Allergy Sufferers page. Available at: http://www.acaai.org/public/checklist/allergy.htm (Accessed May 14, 2007).
